ArTS Archivio della ricerca di Trieste

CROCE', Saveria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.668
EU - Europa 4.875
AS - Asia 1.426
AF - Africa 75
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 11
Totale 15.104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.539
IT - Italia 1.117
PL - Polonia 1.034
SE - Svezia 810
UA - Ucraina 595
CN - Cina 478
HK - Hong Kong 362
DE - Germania 340
SG - Singapore 264
FI - Finlandia 219
BG - Bulgaria 191
TR - Turchia 161
IE - Irlanda 149
GB - Regno Unito 124
CA - Canada 123
CH - Svizzera 62
FR - Francia 58
SN - Senegal 54
RU - Federazione Russa 48
BE - Belgio 43
VN - Vietnam 42
KR - Corea 25
IN - India 23
NL - Olanda 23
CZ - Repubblica Ceca 18
BR - Brasile 16
JP - Giappone 13
EG - Egitto 11
IR - Iran 11
PH - Filippine 11
EU - Europa 10
ID - Indonesia 10
ES - Italia 9
RO - Romania 9
AU - Australia 8
IL - Israele 7
AR - Argentina 6
DK - Danimarca 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
HR - Croazia 4
KE - Kenya 4
MX - Messico 4
NG - Nigeria 4
TW - Taiwan 4
BD - Bangladesh 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AT - Austria 2
CO - Colombia 2
CU - Cuba 2
GR - Grecia 2
NP - Nepal 2
SI - Slovenia 2
TH - Thailandia 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
VE - Venezuela 1
Totale 15.104
Salva come PNG Salva come JPEG
Città #
Warsaw 1.026
Woodbridge 969
Fairfield 933
Ann Arbor 875
Chandler 828
Houston 817
Jacksonville 554
Ashburn 541
Wilmington 459
Seattle 420
Hong Kong 352
Trieste 333
Cambridge 304
Princeton 259
Sofia 191
Singapore 168
Beijing 164
Izmir 151
Dublin 145
Toronto 103
Boardman 83
Dearborn 79
San Diego 66
Milan 63
Falls Church 58
Dakar 54
Bern 52
Helsinki 44
Venezia 42
Brussels 40
Dong Ket 40
Redmond 40
Redwood City 38
Des Moines 36
Chicago 29
Krefeld 29
Udine 28
Verona 25
Rome 24
Bremen 20
Grafing 20
Mestre 19
Norwalk 19
Seoul 19
Phoenix 18
Düsseldorf 17
Shanghai 16
Jinan 15
Kunming 15
Los Angeles 15
Santa Clara 15
Washington 15
Fremont 14
Ottawa 13
Brno 12
Buffalo 12
Guangzhou 12
London 12
Nanchang 12
Nanjing 12
Dallas 11
Venice 11
Columbus 10
Hefei 10
Munich 9
New York 9
Shenyang 9
Fuzhou 8
Menlo Park 8
Padova 8
Palermo 8
São Paulo 8
Taiyuan 8
Duino-Aurisina 7
Gattaran 7
Jakarta 7
Lozzo di Cadore 7
New Haven 7
Pune 7
San Vito Al Tagliamento 7
Shenzhen 7
Alba 6
Amsterdam 6
Central 6
Edinburgh 6
Kocaeli 6
Maniago 6
Naples 6
Piscataway 6
Stockholm 6
Tel Aviv 6
Wuhan 6
Basel 5
Bologna 5
Derby 5
Florence 5
Modena 5
Munro 5
Parma 5
Sacile 5
Totale 11.063
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 375
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 349
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 333
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 298
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 296
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 272
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 267
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 264
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 248
Gut microbiota characterisation in obese patients before and after bariatric surgery 205
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 185
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 173
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 171
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 171
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 163
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 162
Anatomy of Basal Ganglia and Thalamus 162
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 159
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 159
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 157
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 155
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 152
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 148
null 145
null 143
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 142
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 140
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 138
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 136
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 135
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 134
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 134
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 133
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 133
null 132
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 131
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 131
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 130
null 129
null 128
null 125
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 123
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 122
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 121
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 120
null 119
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 119
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 118
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 116
Visual impairments and attention in parkinson's disease 116
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 115
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 115
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 113
null 110
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 109
null 109
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 108
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 108
null 107
Stem cells in the development of hepatocellular carcinoma: identification and expression 107
Deep brain stimulation of the subthalamus: Neuropsychological effects 106
null 105
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 105
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 104
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 104
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients 103
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 103
null 101
null 101
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 101
null 100
null 96
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 94
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 93
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 92
Severity of liver disease with different hepatitis C viral clones. 91
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 91
null 90
null 89
null 87
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 81
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 80
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 80
null 79
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 79
null 78
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 77
Spontaneous porto-femoral shunting in long-standing portal hypertension 77
Variazioni della perfusione dell’epatocarcinoma dopo trattamento con talidomide 76
Hepatocellular carcinoma in the non-cirrhotic liver in Northern Italy: a retrospective study 75
null 75
Epidemiologia del carcinoma epatocellulare 74
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents 73
Diverticular Disease and Rifaximin: An Evidence-Based Review 71
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 71
Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy 69
Presence of Japanese-type HCV in a North-East Italian population 67
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19 67
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis 67
A story of liver and gut microbes: How does the intestinal flora affect liver disease? A review of the literature 66
Totale 13.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.703 0 0 150 522 280 439 280 315 247 162 209 99
2020/20212.303 186 141 193 253 213 233 184 198 106 215 120 261
2021/20221.868 60 98 226 204 58 133 103 126 213 167 103 377
2022/20232.513 216 280 167 346 224 454 55 263 321 38 96 53
2023/20241.573 116 90 73 101 171 135 270 314 30 50 130 93
2024/2025268 56 69 143 0 0 0 0 0 0 0 0 0
Totale 15.752